EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Calibrating Evidence from Negative DNA Methylation Episignatures

Himanshu Goel, Prakriti Goel, Mohit Singhal

Genes · 17.11.2026 · 17 (11) · 1446

DOI: 10.3390/genes17111446 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 17.11.2026. Verfasst von Himanshu Goel und 2 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: A negative blood DNA methylation episignature can change the probability of a suspected disorder. We examined how precisely published data establish the size of that change.

Methods

We calculated ideal precision limits for 57 defining cohorts, reconstructed diagnostic likelihood ratios (LRs) for 14 probe sets across nine disorder groups and mapped those groups to clinical referral records. We compared the bounds with Bayesian ACMG/AMP odds thresholds.

Results

Under the primary conservative procedure, nine negative results reached a supporting-equivalent band and five fell below it. Restricting the reference set to concordant pathogenic or likely pathogenic labels reduced nine to eight. One additional missed affected carrier per signature reduced nine to six. A profile-likelihood analysis yielded seven moderate-equivalent negative bands. Six positive results reached a strong-equivalent band with pooled comparators, compared with none using unaffected controls alone. Of 712 parseable negative referral records, 202 had at least one nominated gene in a group with a supporting-equivalent negative band. Selecting the highest available band makes this an upper-bound illustration of potential coverage.

Conclusions

These LRs describe discrimination of the target disorder in the sampled groups. A positive profile can support the diagnosis while leaving the causal allele uncertain. A negative profile may miss a damaging effect outside the assay’s validated scope. Variant-level PS3 or BS3 requires separate validation for the relevant assay, mechanism and population. No such validation was identified for any signature examined here.

Zitieren

APA

Goel, H., Goel, P., & Singhal, M. (2026). Calibrating Evidence from Negative DNA Methylation Episignatures. Genes, 17(11), 1446. https://doi.org/10.3390/genes17111446

Vancouver

Goel H, Goel P, Singhal M. Calibrating Evidence from Negative DNA Methylation Episignatures. Genes. 2026;17(11):1446. doi:10.3390/genes17111446

BibTeX
@article{Goel2026,
  author = {Goel, Himanshu and Goel, Prakriti and Singhal, Mohit},
  title = {Calibrating Evidence from Negative DNA Methylation Episignatures},
  journal = {Genes},
  year = {2026},
  volume = {17},
  number = {11},
  pages = {1446},
  doi = {10.3390/genes17111446}
}
Kostenlos starten →